Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Neural Regulation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 23, 2025

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Maria-Daniela Cirnaru1, Jordi Creus-Muncunill1, Shareen Nelson2
1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Decreasing TAF1 levels in newborn mice and rats caused motor deficits and reduced cholinergic neurons. This highlights TAF1
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: